The French state has made a 410-million-euro ($468-million) offer to acquire a strategic division of tech firm Atos that includes…
Read More »acquire
Atstock Productions Knight Therapeutics (TSX:GUD:CA) has entered into a definitive asset purchase agreement with Endo Operations and Paladin Pharma, to…
Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
Read More »
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company)…
Read More »